Research shows potential targeted therapy for androgen receptor positive breast cancer

the ONA take:

A daily dose of orally administered enobosarm shows promise in the treatment of metastatic, androgen receptor positive, estrogen receptor positive breast cancer. In addition, enobosarm shows a lesser degree of the side effects associated with endocrine therapy. This targeted therapy could potentially benefit patients with other cancers.

Research shows potential targeted therapy for androgen receptor positive breast cancer
Research shows potential targeted therapy for androgen receptor positive breast cancer
Results from an open label clinical study, evaluating an oral daily dose of the drug enobosarm, shows promise for women with metastatic, androgen receptor positive, estrogen receptor positive breast cancer.
READ FULL ARTICLE From Dana-farber
Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs